Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Long-term Follow-up of Subfoveal Neovascular AMD
Authors not listed
Medical University of Vienna · 2011
Abstract
Treatment naive patients with subfoveal nAMD initially treated monthly with intravitreal anti-VEGF and subsequently PRN, will be included in this study. Patients will be investigated for the first 2 years monthly and subsequently according to disease activity but at least every two months. Patients will be examined with 4m BCVA ETDRS distance visual acuity, reading acuity measured by Radner-Reading-Charts, contrast sensitivity by Pelli-Robson score, microperimetry and HD-OCT.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Anonymous. (2011). Long-term Follow-up of Subfoveal Neovascular AMD. <em>Medical University of Vienna</em>. https://clinicaltrials.gov/study/NCT01608113
Vancouver
Anonymous. Long-term Follow-up of Subfoveal Neovascular AMD. Medical University of Vienna. 2011.
BibTeX
@misc{anon2011Longte,
title = {Long-term Follow-up of Subfoveal Neovascular AMD},
author = {Anonymous},
journal = {Medical University of Vienna},
year = {2011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Michel Giunta 2019
Open access · US-GOV
Exploratory and Descriptive Study Evaluating the Efficacy of Aflibercept in Bimonthly Injections Versus the ''Treat and Extend'' Dosing Regimen
University of Birmingham 2014
Open access · US-GOV
BREVITY: A Phase II Study of Brentuximab Vedotin Using a Response Adapted Design in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity
Archives of Ophthalmology 1993
Citation only
Laser Photocoagulation of Subfoveal Neovascular Lesions of Age-Related Macular Degeneration
Novartis Pharmaceuticals 2013
Open access · US-GOV
A Phase IV, Randomised, Single Masked Study Investigating the Efficacy and Safety of Ranibizumab "Inject and Extend" Using an Intensive Retinal Fluid Retreatment Regimen Compared to a Relaxed Retinal Fluid Retreatment Regimen in Patients With Wet Age-related Macular Degeneration (AMD)
Charite University, Berlin, Germany 2021
Open access · US-GOV
Analysis of the Pathophysiology of Frailty Syndrome and Clinical Development of Frailty Within the Framework of the Innovation Fund Project PRÄP-GO (ANA-PRÄP-GO)
IRCCS San Raffaele 2011
Open access · US-GOV